Ellis Andrea sold BBIO
March 4, 2026 · Form 4 insider transaction
Ellis Andrea sold 64,921 shares of BridgeBio Pharma, Inc. at $64.87 per share, a transaction worth $4.21M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025.; Represents the weighted average sale price of the shares sold from $64.255 to $65.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.